SNT
Click for more information
25.7% 4.4¢ syntara limited

insight, page-6

  1. 8horse
    34,336 Posts.
    lightbulb Created with Sketch. 9075
    clock Created with Sketch.
    25/03/13
    21:56
    Post #: 11585355
    Pxs was trading $1.2 before Negative news for FDA approval, now trading only 32%, lost 68% for FDA delay of approval. It is overreacted, and good buying opportunity for LT holders.
    QRX was knocked back by FDA last year, lost 2/3 value as well, but now recovers almost of loss, that will happen to PXS as well.
    PXS Price at posting: 38.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢ 		Change
0.009(25.7%) 		Mkt cap ! $52.53M
Open High Low Value Volume
3.6¢ 4.4¢ 3.6¢ $183.9K 4.656M

Buyers (Bids)

No. Vol. Price($)
1 1159 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 997342 3
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.